The Food and Drug Administration (FDA) is reportedly interested in conducting a study of so-called “gender-affirming” drugs on minors as young as 13. A pro-“trans” nonprofit initially proposed testing the regimen on adults, but the Biden administration’s FDA “suggested the company broaden its study to include children,” POLITICO reported. READ
No comments:
Post a Comment